Activity of Thiourea-Linked Diamidines against Multidrug-Resistant Staphylococcus aureus
ACS Infectious Diseases · 14.08.2026 · 12 (8) · 2874-2891
DOI: 10.1021/acsinfecdis.6c00572 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 05.08.2026. Verfasst von Yi Jin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina29634, United States. Hauptthemen laut MEDLINE: Thiourea, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Pentamidine. Die Arbeit nennt 74 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Staphylococcus aureus is a leading cause of antibiotic-resistant infections worldwide. Therefore, there is a constant need to develop new growth inhibitors. Pentamidine analogs (PAs) composed of thiourea-linked amidines were evaluated for activity against methicillin-resistant S. aureus (MRSA) and other Gram-positive bacteria. S. aureus, MRSA, Staphylococcus epidermidis, Streptococcus pyogenes, Mycobacterium, and Bacillus were highly susceptible with minimal inhibitory concentration (MIC) values ranging from 1.56 to 6.25 μM, whereas Enterococcus species and Clostridioides difficile were not as susceptible with MICs of 50 to ≥100 μM. For S. aureus, MRSA and VISA strains, PAs showed ∼4-fold lower MICs when compared to pentamidine (PNT). The concentration of PAs needed to lyse 50% of red blood cells (HC50) was ∼16–32-fold higher than their corresponding MICs. For PNT, a lower HC50/MIC range of 1.25–5 was observed. Approximately 60% of MRSA was cleared from infected Caenorhabditis elegans by the PAs. PAs also provided 100% protection in a septicemia model of infected mice. Morphological changes induced by these compounds indicate disruption of cell membrane integrity, where >80% of treated bacterial cells took up propidium iodide in a permeation assay. Importantly, there was a lack of resistance observed with the PAs, compared to the fairly rapid and stable resistance occurrence for drugs commonly used to treat S. aureus infection. These results reflect the potential of such compounds as potential new tools to optimize and combat the menace of drug-resistant S. aureus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina29634, United States.
- NUBAD, LLC, Greenville, South Carolina29605, United States.
ORCID-Profile: Dev P Arya
Förderung
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Jin, Y., Story, S., Chamberlin, J., & Arya, D. P. (2026). Activity of Thiourea-Linked Diamidines against Multidrug-Resistant Staphylococcus aureus. ACS Infectious Diseases, 12(8), 2874-2891. https://doi.org/10.1021/acsinfecdis.6c00572
Vancouver
Jin Y, Story S, Chamberlin J, Arya DP. Activity of Thiourea-Linked Diamidines against Multidrug-Resistant Staphylococcus aureus. ACS Infectious Diseases. 2026;12(8):2874-2891. doi:10.1021/acsinfecdis.6c00572
BibTeX
@article{Jin2026,
author = {Jin, Yi and Story, Sandra and Chamberlin, Jordan and Arya, Dev P},
title = {Activity of Thiourea-Linked Diamidines against Multidrug-Resistant Staphylococcus aureus},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {8},
pages = {2874--2891},
doi = {10.1021/acsinfecdis.6c00572}
}
EUVIMED